Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Dec;62(6):1004–1005. doi: 10.1038/bjc.1990.426

An evaluation of DUPAN-2 in pancreatic cancer and gastrointestinal disease.

E H Cooper 1, M A Forbes 1, M Taylor 1
PMCID: PMC1971573  PMID: 2257202

Full text

PDF
1004

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhargava A. K., Petrelli N. J., Karna A., Parshall P. L., Fitzpatrick J. E., Douglass H. O., Herrera L., Bray K., Gaur P. Serum levels of cancer-associated antigen CA-195 in gastrointestinal cancers and its comparison with CA19-9. J Clin Lab Anal. 1989;3(6):370–377. doi: 10.1002/jcla.1860030610. [DOI] [PubMed] [Google Scholar]
  2. Jalanko H., Kuusela P., Roberts P., Sipponen P., Haglund C. A., Mäkelä O. Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases. J Clin Pathol. 1984 Feb;37(2):218–222. doi: 10.1136/jcp.37.2.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Magnani J. L., Steplewski Z., Koprowski H., Ginsburg V. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res. 1983 Nov;43(11):5489–5492. [PubMed] [Google Scholar]
  4. Mahvi D. M., Seigler H. F., Meyers W. C., Kalthoff H., Schmiegel W. H., Metzgar R. S. DU-PAN-2 levels in serum and pancreatic ductal fluids of patients with benign and malignant pancreatic disease. Pancreas. 1988;3(4):488–493. doi: 10.1097/00006676-198808000-00020. [DOI] [PubMed] [Google Scholar]
  5. Metzgar R. S., Gaillard M. T., Levine S. J., Tuck F. L., Bossen E. H., Borowitz M. J. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Cancer Res. 1982 Feb;42(2):601–608. [PubMed] [Google Scholar]
  6. Metzgar R. S., Rodriguez N., Finn O. J., Lan M. S., Daasch V. N., Fernsten P. D., Meyers W. C., Sindelar W. F., Sandler R. S., Seigler H. F. Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci U S A. 1984 Aug;81(16):5242–5246. doi: 10.1073/pnas.81.16.5242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Sakurabayashi I., Yamada T., Kawai T., Yamanaka T. [Clinical evaluation of a pancreatic cancer-associated glycoprotein antigen, DU-PAN-2. I. Enzymeimmunoassay and distribution of serum values in healthy persons]. Rinsho Byori. 1986 Jun;34(6):705–710. [PubMed] [Google Scholar]
  8. Sawabu N., Toya D., Takemori Y., Hattori N., Fukui M. Measurement of a pancreatic cancer-associated antigen (DU-PAN-2) detected by a monoclonal antibody in sera of patients with digestive cancers. Int J Cancer. 1986 May 15;37(5):693–696. doi: 10.1002/ijc.2910370509. [DOI] [PubMed] [Google Scholar]
  9. Takemori Y., Sawabu N., Satomura Y., Ohta H., Watanabe H., Okai T., Mai M., Hattori N., Akiyama T., Hashimoto T. [Determination of serum DU-PAN-2 by enzyme immunoassay in patients with various digestive cancers]. Gan To Kagaku Ryoho. 1987 Jan;14(1):119–126. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES